12:00 AM
 | 
Aug 21, 2006
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 8/18 cls
Acadia (ACAD) Banc of America Securities David Witzke New Buy 41% $7.58
Witzke set a $10 target. He said the company has important milestones over the next 12 months, including interim Phase II data for ACP-103 to treat schizophrenia this half.
Acorda (ACOR) Banc of America Securities David Witzke New Buy 1% $3.43
Witzke set a $5 target....

Read the full 462 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >